Free Shipping on purchases over €100

Lierac Homme Bálsamo Aftershave

Lierac Homme Aftershave Balm

Lierac Homme Aftershave Balm helps prevent symptoms caused by irritation or inflammation after shaving. It deeply moisturises and prevents tightness and burning sensations in the skin tissue. Fragrance free.

SKU: LI4056
Sold out
14.20
€19.90
Temporarily sold out

Subscribe and we will notify you when it becomes available again.

Pharmaceutical Care

Safe medication sales

Secure shipping

INFO AND TECHNICAL SPECIFICATIONS

Lierac Homme Aftershave Balm is composed of ingredients such as glycerin, which acts immediately to deeply moisturise the skin. It also optimises the preservation of its natural moisture for a long time. It has emollient properties that benefit the softness of the skin and restores elasticity and suppleness. This is because it promotes the production of elastin and collagen.

It helps prevent damage caused by external agents and acts against the signs of premature ageing. It also encourages cell renewal.

It has soothing properties that help to relieve irritation, redness, inflammation and eczema on the complexion. Therefore, it is a great ally to apply after shaving.

Another of its benefits is that it helps to regenerate damaged tissue and improves healing. It also helps to slow down hair growth and thus makes shaving easier.

It is fragrance-free and therefore totally hypoallergenic. Its texture is light and whitish, yet it absorbs quickly without leaving greasy or white traces on the skin.

It comes in a 75 ml tube of gel, which has a nozzle that makes it much easier to use.

Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
  • Vendor: Laboratorios Lierac Paris
  • Vendor address: 10 Rue de l'Abbaye, 75006 Paris
  • Phone number: +33 1 45 48 77 00
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.